Test Description: Prostatic Cancer Probability Screen

The Prostatic Cancer Probability Screen is a diagnostic panel designed to assess the risk of prostate cancer. It typically includes a combination of tests such as Prostate-Specific Antigen (PSA), Free PSA, Prostate Health Index (PHI), and possibly other biomarkers or imaging studies. These tests help estimate the likelihood of prostate cancer in individuals with elevated PSA levels or other symptoms. The screen is used to determine the need for further testing, such as a prostate biopsy, and to guide decisions on prostate cancer monitoring or treatment.